Phone: (011) 7541-421, 3409-301, 3409-335, 6547-293, 3409-310
E-mail: Standards sales: prodaja@iss.rs Education: iss-edukacija@iss.rs Information about standards: infocentar@iss.rs
Stevana Brakusa 2, 11030 Beograd
Main menu

ISO/FDIS 10993-3

Biological evaluation of medical devices — Part 3: Evaluation of genotoxicity, carcinogenicity, reproductive toxicity and developmental toxicity

General information

50.20     Apr 16, 2026

ISO

ISO/TC 194

International Standard

11.100.20  

Scope

ISO 10993-3:2014 specifies strategies for risk estimation and selection of hazard identification tests, with respect to the possibility of the following potentially irreversible biological effects arising as a result of exposure to medical devices:

genotoxicity;
carcinogenicity;
reproductive and developmental toxicity.

ISO 10993-3:2014 is applicable when the need to evaluate a medical device for potential genotoxicity, carcinogenicity, or reproductive toxicity has been established.

Life cycle

PREVIOUSLY

PUBLISHED
ISO 10993-3:2014

PUBLISHED
ISO/TR 10993-33:2015

NOW

PROJECT
ISO/FDIS 10993-3
50.20 Proof sent to secretariat or FDIS ballot initiated: 8 weeks
Apr 16, 2026

National adoptions

Biological evaluation of medical devices - Part 3: Evaluation of genotoxicity, carcinogenicity, reproductive toxicity, and developmental toxicity (ISO/FDIS 10993-3:2026)

50.20   Proof sent to secretariat or FDIS ballot initiated: 8 weeks

Z076 more

Preview

To view the full content, you need to register or to log in to your account by clicking on the "Log in" button

Login